Effect of cisapride on gastroesophageal reflux disease of children.
Dinler
G
G
Ozen
H
H
Koçak
N
N
Yüce
A
A
Gürakan
F
F
D000293:Adolescent; D000367:Age Factors; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D020117:Cisapride / Q000627:therapeutic use*; D004947:Esophagus / Q000503:physiopathology; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D018670:Monitoring, Ambulatory; D011899:Ranitidine / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D005765:Gastrointestinal Agents; D011899:Ranitidine; D020117:Cisapride